Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.310
+0.010 (0.77%)
Feb 25, 2026, 9:54 AM EST - Market open
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $2.64 million as of February 25, 2026. Its market cap has decreased by -38.50% in one year.
Market Cap
2.64M
Enterprise Value
2.70M
1-Year Change
-38.50%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $2.64M, a decrease of -78.50%. That is a compound annual growth rate of -20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 2.80M | 12.00% |
| Dec 31, 2025 | 2.50M | -26.47% |
| Dec 31, 2024 | 3.40M | -24.44% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
| Jun 21, 2019 | 12.30M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Propanc Biopharma | 3.02M |
| Enveric Biosciences | 2.86M |
| Oragenics | 2.76M |
| SciSparc | 2.68M |
| XORTX Therapeutics | 2.59M |
| Adial Pharmaceuticals | 2.59M |
| Psyence Biomedical | 2.56M |
| Lyra Therapeutics | 2.56M |